Your browser doesn't support javascript.
loading
Complete response to definitive chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma.
Habu, Takumi; Kumanishi, Ryosuke; Ogata, Takatsugu; Fujisawa, Takeshi; Mishima, Saori; Kotani, Daisuke; Kadowaki, Shigenori; Nakamura, Masaki; Hojo, Hidehiro; Fujiwara, Hisashi; Kumagai, Shogo; Koyama, Shohei; Fujita, Takeo; Kinoshita, Takahiro; Nishikawa, Hiroyoshi; Yano, Tomonori; Tajika, Masahiro; Muro, Kei; Mitsunaga, Shuichi; Kojima, Takashi; Bando, Hideaki.
Affiliation
  • Habu T; Department of Gastric Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
  • Kumanishi R; Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Kashiwa, Japan.
  • Ogata T; Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Fujisawa T; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Mishima S; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Kotani D; Division of Radiation Oncology and Particle Therapy, National Cancer Center Hospital East, Kashiwa, Japan.
  • Kadowaki S; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Nakamura M; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Hojo H; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Fujiwara H; Division of Radiation Oncology and Particle Therapy, National Cancer Center Hospital East, Kashiwa, Japan.
  • Kumagai S; Division of Radiation Oncology and Particle Therapy, National Cancer Center Hospital East, Kashiwa, Japan.
  • Koyama S; Division of Esophageal Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
  • Fujita T; Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Kashiwa, Japan.
  • Kinoshita T; Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Kashiwa, Japan.
  • Nishikawa H; Division of Esophageal Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
  • Yano T; Department of Gastric Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
  • Tajika M; Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Kashiwa, Japan.
  • Muro K; Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Kashiwa, Japan.
  • Mitsunaga S; Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Kojima T; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Bando H; Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Esophagus ; 20(3): 533-540, 2023 07.
Article in En | MEDLINE | ID: mdl-36750480
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Carcinoma, Squamous Cell / Esophageal Squamous Cell Carcinoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Esophagus Year: 2023 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Carcinoma, Squamous Cell / Esophageal Squamous Cell Carcinoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Esophagus Year: 2023 Type: Article Affiliation country: Japan